The Chromatin-Modifying Protein HMGA2 Promotes Atypical Teratoid/Rhabdoid Cell Tumorigenicity
Bernard E. Weissman(University of North Carolina at Chapel Hill), Eric H. Raabe(Johns Hopkins University), Anat Erdreich‐Epstein(University of Southern California), Yasumichi Kuwahara(Kyoto Prefectural University of Medicine), Marianne Hütt-Cabezas(NYU Langone Health), Melanie Weingart(Sidney Kimmel Comprehensive Cancer Center), Harpreet Kaur, Jingying Xu(Tongji University), Charles G. Eberhart(The University of Texas MD Anderson Cancer Center)
Cited by 0
Related Papers
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711